Immix Biopharma (NASDAQ:IMMX – Get Free Report) had its target price raised by Needham & Company LLC from $21.00 to $30.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 194.15% […]

TTM Technologies (NASDAQ:TTMI – Free Report) had its target price lowered by Needham & Company LLC from $220.00 to $175.00 in a research note published on Monday morning, Marketbeat.com reports. The firm currently has a buy rating on the technology company’s stock. TTMI has been the topic of several other research reports. B. Riley Financial […]